newsfilter
← Latest News
Business Wire·

Horizon Therapeutics plc Responds to U.S. Federal Trade Commission (FTC) Action to Block Acquisition by Amgen

Horizon Therapeutics plc (NASDAQ:HZNP) today issued the following statement in response to the FTC's complaint seeking to block Amgen's proposed acquisition of the Company: "This acquisition has the potential to